We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Matrix Service
MTRX
$326M
| $3.82M | 0.02% |
292,211
-17,699
| -6% | -$252K |
|
477
Skyward Specialty Insurance
SKWD
$2.43B
| $3.81M | 0.02% |
80,192
-12,760
| -14% | -$638K |
|
478
American States Water
AWR
$3.36B
| $3.81M | 0.02% |
51,989
+1,738
| +3% | +$129K |
|
479
H&R Block
HRB
$5.58B
| $3.72M | 0.01% |
73,599
-24,535
| -25% | -$1.3M |
|
480
Hyster-Yale Materials Handling
HY
$599M
| $3.71M | 0.01% |
100,663
-7,599
| -7% | -$296K |
|
481
Gossamer Bio
GOSS
$82.9M
| $3.7M | 0.01% |
1,408,118
+316,554
| +29% | +$698K |
|
482
Alector
ALEC
$168M
| $3.64M | 0.01% |
1,230,974
-91,908
| -7% | -$202K |
|
483
Astec Industries
ASTE
$1.16B
| $3.61M | 0.01% |
74,909
-115,994
| -61% | -$5.07M |
|
|
ZEUS
484
DELISTED
Olympic Steel
ZEUS
| $3.58M | 0.01% |
117,728
-283
| -0.2% | -$9.28K |
|
485
United Natural Foods
UNFI
$3.08B
| $3.58M | 0.01% |
95,243
-7,493
| -7% | -$205K |
|
|
HTBK
486
DELISTED
Heritage Commerce
HTBK
| $3.58M | 0.01% |
360,543
+327,138
| +979% | +$3.29M |
|
487
Independent Bank Corp
IBCP
$787M
| $3.56M | 0.01% |
114,919
-520
| -0.5% | -$16.8K |
|
488
DXC Technology
DXC
$1.82B
| $3.55M | 0.01% |
260,549
-32,355
| -11% | -$459K |
|
489
Granite Ridge Resources
GRNT
$627M
| $3.54M | 0.01% |
653,827
+131,539
| +25% | +$717K |
|
490
Tyra Biosciences
TYRA
$1.9B
| $3.52M | 0.01% |
251,562
-143,737
| -36% | -$1.64M |
|
491
Aviat Networks
AVNW
$265M
| $3.46M | 0.01% |
150,784
-14,249
| -9% | -$327K |
|
492
Bristol-Myers Squibb
BMY
$133B
| $3.41M | 0.01% |
75,589
+39,487
| +109% | +$1.84M |
|
493
Tanger
SKT
$4.67B
| $3.4M | 0.01% |
100,611
-15,537
| -13% | -$506K |
|
494
Franklin Covey
FC
$242M
| $3.38M | 0.01% |
174,324
+96,054
| +123% | +$1.9M |
|
495
Delek US
DK
$4.16B
| $3.38M | 0.01% |
104,698
+9,176
| +10% | +$240K |
|
496
SharkNinja
SN
$22.9B
| $3.36M | 0.01% |
32,546
-2,215
| -6% | -$253K |
|
|
CMRC
497
Commerce.com Inc Series 1
CMRC
$258M
| $3.34M | 0.01% |
670,020
-128,770
| -16% | -$619K |
|
498
OraSure Technologies
OSUR
$279M
| $3.33M | 0.01% |
1,036,797
-24,594
| -2% | -$77.2K |
|
499
Arteris
AIP
$1.38B
| $3.24M | 0.01% |
320,720
-28,163
| -8% | -$268K |
|
500
FerroAtlántica
GSM
$594M
| $3.23M | 0.01% |
+710,171
| New | +$3.04M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.